With production value of USD559 billion, China accounts for 72.4% of the Asia Pacific total in 2023. The industry’s exports share decreases in 2023 to 5.8% of total production output. The industry’s profitability decreases and stands at 19.8% of production value in 2023, the seventh highest regionally. The costs of the industry increase by 0.1% in 2023, largely driven by rising labour costs. The total number of companies remains unchanged in 2023. The industry is fragmented, with the top five companies generating 16.2% of total production value in 2023. Shanghai Pharmaceuticals Holding Co Ltd is the largest company in China, generating 6.4% of the industry’s total production value in 2023. China has the largest market size for pharmaceuticals regionally, with demand reaching USD678 billion in 2023. B2B drives market demand, with B2B spending representing 81.8% of total demand in 2023. The market is dominated by domestic suppliers, as imports account for 8.4% of total market size in 2023.
Delivery:
Files are delivered directly into your account soon after payment is received and any tax is certification is verified (where applicable).
This report comes in PDF.
This Euromonitor industrial report provides unique information on Pharmaceuticals in China: ISIC 2423. With this industrial report, you’ll be able to explore the industry from its sources of supply to its buyers. The Pharmaceuticals in China: ISIC 2423 report includes: Industry datagraphics including production data, exports, imports, cost structure, and profitability
Pharmaceuticals and Medical Equipment is an aggregation of Pharmaceuticals, Medical and Surgical Equipment.
See All of Our DefinitionsIf you purchase a report that is updated in the next 60 days, we will send you the new edition and data extraction Free!